Ubiquitin C‐terminal hydrolase‐L1 as a biomarker for ischemic and traumatic brain injury in rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Neuroscience

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1460-9568.2010.07097.xPMID 20384815PMCID PMC2855688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*

  2010cited by this paper
• Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006

  2010cited by this paper
• Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion

  2009cited by this paper
• Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

  2008cited by this paper
• Neuroproteomics and systems biology‐based discovery of protein biomarkers for traumatic brain injury and clinical validation

  2008cited by this paper
• The Phosphorylated Axonal Form of the Neurofilament Subunit NF-H (pNF-H) as a Blood Biomarker of Traumatic Brain Injury

  2008cited by this paper
• Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury

  2008influential reference
• Glial fibrillary acidic protein is highly correlated with brain injury.

  2008cited by this paper
• Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

  2007cited by this paper
• Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury

  2007cited by this paper
• Protein Aggregation and Proteasome Dysfunction After Brain Ischemia

  2007cited by this paper
• Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome

  2007cited by this paper
• Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain.

  2007cited by this paper
• Serum Biomarker Concentrations and Outcome after Pediatric Traumatic Brain Injury

  2007cited by this paper
• Axonal damage and outcome in subarachnoid haemorrhage

  2006cited by this paper
• Identification of Inflicted Traumatic Brain Injury in Well-Appearing Infants Using Serum and Cerebrospinal Markers: A Possible Screening Tool

  2006cited by this paper
• Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats*

  2006influential reference
• Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths

  2006cited by this paper
• Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.

  2005cited by this paper
• Proteomic identification of biomarkers of traumatic brain injury

  2005influential reference
• Ubiquitin C-Terminal Hydrolase L-1 Is Essential for the Early Apoptotic Wave of Germinal Cells and for Sperm Quality Control During Spermatogenesis1

  2005cited by this paper
• Novel Surrogate Markers for Acute Brain Damage: Cerebrospinal Fluid Levels Corrrelate with Severity of Ischemic Neurodegeneration in the Rat

  2005cited by this paper
• Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

  2005cited by this paper
• Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

  2005cited by this paper
• NONSPECIFIC INCREASE OF SYSTEMIC NEURON-SPECIFIC ENOLASE AFTER TRAUMA: CLINICAL AND EXPERIMENTAL FINDINGS

  2005cited by this paper
• Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

  2004cited by this paper
• A Novel Marker for Traumatic Brain Injury: CSF αII-Spectrin Breakdown Product Levels

  2004influential reference
• Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats

  2004cited by this paper
• Release of S100B Differs During Ischemia and Reperfusion of the Liver, the Gut, and the Kidney in Rats

  2004cited by this paper
• GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome

  2004cited by this paper
• Proteins released from degenerating neurons are surrogate markers for acute brain damage.

  2004cited by this paper
• Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

  2004cited by this paper
• The effect of voluntary exercise exposure on histological and neurobehavioral outcomes after ischemic brain injury in the rat.

  2003cited by this paper
• Biochemical serum markers for brain damage: A short review with emphasis on clinical utility in mild head injury

  2003cited by this paper
• Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.

  2003cited by this paper
• Stroke in the elderly.

  2003cited by this paper
• Circulating S100B is increased after bilateral femur fracture without brain injury in the rat.

  2003cited by this paper
• Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

  2002cited by this paper
• C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.

  2002cited by this paper
• Exploratory clinical testing of neuroscience drugs

  2002cited by this paper
• Protein Aggregation after Focal Brain Ischemia and Reperfusion

  2001cited by this paper
• Design and statistical issues in multicenter trials of severe head injury

  2001cited by this paper
• Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

  2001cited by this paper
• Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats

  2001cited by this paper
• Early TNF-alpha levels correlate with ischaemic stroke severity.

  2001cited by this paper
• Early TNF‐α levels correlate with ischaemic stroke severity

  2001cited by this paper
• Evidence for an Interaction between Ubiquitin-Conjugating Enzymes and the 26S Proteasome

  2000cited by this paper
• Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation.

  2000cited by this paper
• Traumatic Brain Damage: Serum S-100 Protein Measurements Related to Neuroradiological Findings

  2000influential reference
• Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis.

  2000cited by this paper
• Serum markers of brain damage and outcome prediction in patients after severe head injury.

  1999influential reference
• Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

  1999influential reference
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.

  1999cited by this paper
• Structural basis for the specificity of ubiquitin C‐terminal hydrolases

  1999cited by this paper
• Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.

  1998cited by this paper
• Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury

  1998cited by this paper
• Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes

  1997cited by this paper
• S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

  1997influential reference
• Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues.

  1996cited by this paper
• Neuron-specific enolase as an aid to outcome prediction in head injury.

  1996influential reference
• Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury.

  1995influential reference
• Spectrin Proteolysis in the Hippocampus: A Biochemical Marker for Neuronal Injury and Neuroprotection

  1993cited by this paper
• Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases.

  1992influential reference
• Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus.

  1989cited by this paper
• Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage

  1989cited by this paper
• Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo.

  1988cited by this paper
• Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus.

  1988cited by this paper
• The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis.

  1981influential reference
• Physiology and phylogenesis of emotional expression.

  1967cited by this paper

• Clinical Potential of Extracellular Vesicles in Central Nervous System Pathologies

  2025influential citation
• Study of ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and interleukin-6 levels in an experimental head trauma model in rabbits

  2025cites this paper
• NEUROFILAMENT (NF-L) IN THE RAT CEREBRAL ISCHEMIA EXPERIMENT

  2025cites this paper
• Plasma biomarkers in chronic mild traumatic brain injury: A review.

  2025cites this paper
• Can Serum GFAP and UCH-L1 Replace CT in Assessing Acute Ischemic Stroke Severity?

  2025cites this paper
• A Bioinformatic Study of Genetics Involved in Determining Mild Traumatic Brain Injury Severity and Recovery

  2025cites this paper
• The Importance of Increased Serum GFAP and UCH-L1 Levels in Distinguishing Large Vessel from Small Vessel Occlusion in Acute Ischemic Stroke

  2024cites this paper
• Impact of fluorosis on molecular predictors in pathogenesis of type 2 diabetes associated microvascular complications.

  2024cites this paper
• Prediction Value of Initial Serum Levels of SERPINA3 in Intracranial Pressure and Long-Term Neurological Outcomes in Traumatic Brain Injury

  2024cites this paper
• Diagnostic implications of ubiquitination-related gene signatures in Alzheimer's disease

  2024cites this paper
• Insights from Rodent Models for Improving Bench-to-Bedside Translation in Traumatic Brain Injury.

  2024cites this paper
• Diagnostic and prognostic performance of urine ubiquitin carboxy-terminal hydrolase L1 across multiple acute brain injury types – A longitudinal prospective cohort study

  2024influential citation
• Unveiling the predictive power of biomarkers in traumatic brain injury: A narrative review focused on clinical outcomes.

  2024cites this paper
• Minimally invasive serial collection of cerebrospinal fluid reveals sex-dependent differences in neuroinflammation in a rat model of mild traumatic brain injury

  2024cites this paper
• Diagnostic role of serum testican and ubiquitin levels in patients with head trauma

  2024cites this paper
• Biomarkers of Acute Brain Injury

  2024cites this paper
• Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease

  2024cites this paper
• The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury

  2024cites this paper
• Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours

  2024cites this paper
• Translating from mice to humans: using preclinical blood-based biomarkers for the prognosis and treatment of traumatic brain injury

  2023cites this paper
• A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.

  2023cites this paper
• The Effect of Early Application of Synthetic Peptides 19-2.5 and 19-4LF to Improve Survival and Neurological Outcome in a Mouse Model of Cardiac Arrest and Resuscitation

  2023influential citation
• Current trends and future perspectives for enhanced drug delivery to central nervous system in treatment of stroke.

  2023cites this paper
• The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury

  2023influential citation
• Cerebrospinal Fluid Biomarkers for Diagnosis and the Prognostication of Acute Ischemic Stroke: A Systematic Review

  2023cites this paper
• Serum biomarkers based neurotrauma severity scale: a study in the mice model of fluid percussion injury.

  2022influential citation
• The Prognostic Value of Deleted in Colorectal Cancer (DCC) Receptor and Serum Netrin-1 in Severe Traumatic Brain Injury

  2022cites this paper
• Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

  2022cites this paper
• A Literature Review of Traumatic Brain Injury Biomarkers

  2022cites this paper
• Military traumatic brain injury: a challenge straddling neurology and psychiatry

  2022cites this paper
• Sex Differences in Cerebral Blood Flow and Serum Inflammatory Cytokines and Their Relationships in Mild Traumatic Brain Injury

  2022cites this paper
• Predicting Clinical Outcomes 7–10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2

  2022cites this paper
• Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?

  2022influential citation
• FDG-PET/CT Assessment of the Cerebral Protective Effects of Hydrogen in Rabbits with Cardiac Arrest.

  2022cites this paper
• Fluid biomarkers in stroke: From animal models to clinical care

  2022cites this paper
• Analysis of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase L1 in Postmortem Serum and Cerebrospinal Fluid in Traumatic Cerebral Deaths

  2021cites this paper
• Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus.

  2021cites this paper
• Acute and Lingering Impairments in Post-Concussion Postural Control

  2021cites this paper
• Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

  2021cites this paper
• Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species

  2021cites this paper
• Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study.

  2021cites this paper
• Newly-identified blood biomarkers of neurological damage are correlated with infarct volume in patients with acute ischemic stroke.

  2021cites this paper
• Medico-legal application of ubiquitin C-terminal hydrolase L1 in mild and moderate head injured patients

  2021cites this paper
• Blood-Based Biomarkers: A Forgotten Friend of Hyperacute Ischemic Stroke

  2021cites this paper
• Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients.

  2020cites this paper
• Amyloid-β Protein and Neuroglobin Protein as Biomarkers on Brainstem Following Traumatic Brain Injury in Rats

  2020cites this paper
• Glutamate biomarkers in comprehensive diagnostics of acute and chronic brain ischemia

  2020cites this paper
• Case Study of a Breacher: Investigation of Neurotrauma Biomarker Levels, Self-reported Symptoms, and Functional MRI Analysis Before and After Exposure to Measured Low-Level Blast.

  2020cites this paper
• Neuron-Specific Markers and their Correlation with Neurological Scales in Patients with Acute Neuropathologies

  2020cites this paper
• Neuroplasticity Biomarkers in Experimental Stroke Recovery

  2019cites this paper
• Neurochemical biomarkers in spinal cord injury

  2019cites this paper
• Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III

  2019cites this paper
• Upcoming diagnostic biomarkers with promising prospects in neurological disorders

  2019cites this paper
• Protein biomarkers of epileptogenicity after traumatic brain injury.

  2019cites this paper
• The diagnostic value of serum UCHL-1 and S100-B levels in differentiate epileptic seizures from psychogenic attacks.

  2019cites this paper
• Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation

  2019cites this paper
• An update on diagnostic and prognostic biomarkers for traumatic brain injury

  2018cites this paper
• The Use of Blood-Based Biomarkers to Improve the Design of Clinical Trials of Traumatic Brain Injury

  2018cites this paper
• Diagnostic and Immunosuppressive Potential of Elevated Mir-424 Levels in Circulating Immune Cells of Ischemic Stroke Patients

  2018cites this paper
• A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury

  2018cites this paper
• Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.

  2018cites this paper
• Development of a systems‐based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury

  2018cites this paper
• Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases

  2018cites this paper
• The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis

  2018cites this paper
• Investigation of UCH‐L1 levels in ischemic stroke, intracranial hemorrhage and metabolic disorder induced impaired consciousness

  2017influential citation
• Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest

  2017cites this paper
• cPKCγ‐mediated down‐regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK‐mTOR pathway

  2017cites this paper
• Protein Characterization of Extracellular Microvesicles/Exosomes Released from Cytotoxin-Challenged Rat Cerebrocortical Mixed Culture and Mouse N2a Cells

  2017cites this paper
• Do Low Serum UCH-L1 and TDP-43 Levels Indicate Disturbed Ubiquitin-Proteosome System in Autism Spectrum Disorder?

  2017cites this paper
• Biofluid Proteomics and Biomarkers in Traumatic Brain Injury.

  2017cites this paper
• Effects of concussion on the blood–brain barrier in humans and rodents

  2017cites this paper
• NUCLEC ACDS AND OTHER ANALYTES

  2017cites this paper
• Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries

  2017cites this paper
• Biomarkers for acute diagnosis and management of stroke in neurointensive care units

  2016cites this paper
• Serum Carnosine Dipeptidase 1 and Ubiquitin C - Terminal Hydrolase L1 as Markers of Brain Damage in Patients After Carotid Endarterectomy -

  2016cites this paper
• Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury*

  2016cites this paper
• Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore

  2016cites this paper
• Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study

  2016cites this paper
• Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients

  2016cites this paper
• Interfacial Enzyme Function Visualized Using Neutron, X-Ray, and Light-Scattering Methods

  2016cites this paper
• Folding Dynamics and Structural Basis of the Enzyme Mechanism of Ubiquitin C-Terminal Hydroylases

  2016cites this paper
• A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury

  2016cites this paper
• Biomarkers of Acute Brain Injury in the Emergency Department

  2016cites this paper
• Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats

  2016cites this paper
• Microdialysis as Clinical Evaluation of Therapeutic Hypothermia in Rat Subdural Hematoma Model.

  2016cites this paper
• Spectrin Breakdown Products in the Investigation of Blast Induced Traumatic Brain Injury ” Major

  2016cites this paper
• Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis.

  2015cites this paper
• [Cellular and molecular mechanisms of radiation-induced brain injury: can peripheral markers be detected?].

  2015cites this paper
• Biomarkers Improve Clinical Outcome Predictors of Mortality Following Non-Penetrating Severe Traumatic Brain Injury

  2015cites this paper
• Biomarkers in traumatic brain injury: a review

  2015cites this paper
• Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report.

  2015cites this paper
• Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward

  2015cites this paper
• Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury

  2015cites this paper
• Potential of UCHL1 as biomarker for destruction of pancreatic beta cells.

  2015cites this paper
• Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1.

  2015cites this paper
• Biomarkers for CNS Injury and Regeneration

  2015cites this paper
• MicroRNAs as Brain Injury Biomarker

  2015cites this paper
• Chapter 16 - Biomarkers

  2015cites this paper
• Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats

  2015cites this paper
• University of Birmingham Translational biomarkers of neurotoxicity

  2015cites this paper